efavirenz 400 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG [Symfi]
RxNorm concept 2101004, branded drug component (sbdc).
- RxCUI
- 2101004
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2101004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
efavirenz 400 MG / lamiVUDine 300 MG / tenofovir disoproxil fumarate 300 MG [Symfi]
Related concepts
- efavirenz 400 MG / lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Symfi] (SBD, constitutes)
- Symfi (BN, has ingredient)
- lamivudine 300 MG (SCDC, tradename of)
- tenofovir disoproxil fumarate 300 MG (SCDC, tradename of)
- efavirenz 400 MG (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2101004 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2101004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2101004. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.